Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
Acadia Pharmaceuticals recently released the results of their Phase 3 trial of Nuplazid, a treatment for the psychosis that Parkinson's disease patients experience. This medication has been approved since 2016,…